Tetratherix launches precision medicine franchise via Tetramatrix; signs exclusive US$3m/year deal with Superpower Health for ...
A bull Put options strategy is favored over direct equity due to AMPH’s lack of moat or high growth. My last article about Amphastar Pharmaceuticals, Inc. ( AMPH) was in July, last year. This is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results